Agilent Technologies, Inc. (A) Tops Q3 EPS by 4c, Posts Q4 and FY11 Guidance
Tweet
Share
E-mailGet Alerts A Hot Sheet
Price: $149.29 +0.71%
EPS Growth %: +8.8%
Financial Fact:
Basic (in shares): 326M
Today's EPS Names:
OFLX, VAXX, NMRD, More
EPS Growth %: +8.8%
Financial Fact:
Basic (in shares): 326M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Agilent Technologies, Inc. (NYSE: A) reported Q3 EPS of $0.77, $0.04 better than the analyst estimate of $0.73. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.66 billion.
Agilent Technologies, Inc. sees Q4 2011 EPS of $0.79-$0.81, versus the consensus of $0.81. Agilent Technologies, Inc. sees Q4 2011 revenue of $1.74-$1.76 billion, versus the consensus of $1.76 billion.
Agilent Technologies, Inc. sees FY2011 EPS of $2.90-$2.92, versus the consensus of $2.88. Agilent Technologies, Inc. sees FY2011 revenue of $6.64-$6.66 billion, versus the consensus of $6.62 billion.
Agilent Technologies, Inc. sees Q4 2011 EPS of $0.79-$0.81, versus the consensus of $0.81. Agilent Technologies, Inc. sees Q4 2011 revenue of $1.74-$1.76 billion, versus the consensus of $1.76 billion.
Agilent Technologies, Inc. sees FY2011 EPS of $2.90-$2.92, versus the consensus of $2.88. Agilent Technologies, Inc. sees FY2011 revenue of $6.64-$6.66 billion, versus the consensus of $6.62 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
